CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Innovation/Tech Officer sold 35,000 shares at $6.75 ($236,250)
- 4 Open-market sale Chief Innovation/Tech Officer sold 40,792 shares at $6.50 ($265,148)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
Page 23 of 35 · 690 filings